Quarterly report · Q2

Period2022-01-01 → 2022-06-30
Filed2022-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥840m2022-01-01 → 2022-06-30Cons.Net sales
Revenue¥2.0bn2021-01-01 → 2021-12-31Cons.Net sales (5-year summary)
Revenue¥430m2021-01-01 → 2021-06-30Cons.Net sales
Operating income−¥312m2022-01-01 → 2022-06-30Cons.Operating income
Operating income−¥777m2021-01-01 → 2021-06-30Cons.Operating income
Ordinary income−¥306m2022-01-01 → 2022-06-30Cons.Ordinary income
Ordinary income−¥523m2021-01-01 → 2021-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥775m2021-01-01 → 2021-06-30Cons.Ordinary income
Profit before tax−¥349m2022-01-01 → 2022-06-30Cons.Income before income taxes
Profit before tax−¥781m2021-01-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)−¥359m2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥534m2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥776m2021-01-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income−¥359m2022-01-01 → 2022-06-30Cons.Profit loss
Net income−¥776m2021-01-01 → 2021-06-30Cons.Profit loss
Total assets¥5.2bnat 2022-06-30Cons.Assets
Total assets¥5.4bnat 2021-12-31Cons.Assets
Total assets¥3.7bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥792mat 2022-06-30Cons.Liabilities
Total liabilities¥1.1bnat 2021-12-31Cons.Liabilities
Net assets / equity¥4.4bnat 2022-06-30Cons.Net assets
Net assets / equity¥4.3bnat 2021-12-31Cons.Net assets
Net assets / equity¥3.1bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥4.7bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥3.8bnat 2021-12-31Cons.Cash and deposits
Cash & equivalents¥4.7bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥3.8bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥3.2bnat 2021-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.3bnat 2020-12-31dCons.Cash and cash equivalents
Operating cash flow¥585m2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥1.5bn2021-01-01 → 2021-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥963m2021-01-01 → 2021-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥57m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥42m2021-01-01 → 2021-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥34m2021-01-01 → 2021-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥166m2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
Financing cash flow¥1.1bn2021-01-01 → 2021-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥102m2021-01-01 → 2021-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-26.532022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-25.252022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-42.12021-01-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-62.562021-01-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-39.462021-04-01 → 2021-06-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio84.7%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio79.3%at 2021-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio84.5%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥286m
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥286m
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥547m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥553m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥553m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥235m
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentsegment profit2021-01-01 → 2021-06-30−¥922m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue2021-01-01 → 2021-06-30¥430m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue external2021-01-01 → 2021-06-30¥430m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentsegment profit2021-01-01 → 2021-06-30¥145m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 439
ItemContextValueUnit
Valuation difference on available for sale securitiesPrior1YearInstant-630000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-1871000JPY
Deferred gains or losses on hedgesPrior1YearInstant6578000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant94178000JPY
Foreign currency translation adjustmentPrior1YearInstant7841000JPY
Foreign currency translation adjustmentCurrentQuarterInstant44504000JPY
Valuation and translation adjustmentsPrior1YearInstant13789000JPY
Valuation and translation adjustmentsCurrentQuarterInstant136811000JPY
Subscription rights to sharesPrior1YearInstant9840000JPY
Subscription rights to sharesCurrentQuarterInstant7999000JPY
Net assetsPrior1YearInstant4315572000JPY
Net assetsCurrentQuarterInstant4425947000JPY
Liabilities and net assetsPrior1YearInstant5432560000JPY
Liabilities and net assetsCurrentQuarterInstant5218214000JPY
Net salesPrior1YTDDuration430010000JPY
Net salesCurrentYTDDuration839543000JPY
Cost of salesPrior1YTDDuration69043000JPY
Cost of salesCurrentYTDDuration83078000JPY
Gross profitPrior1YTDDuration360967000JPY
Gross profitCurrentYTDDuration756465000JPY
Selling general and administrative expensesPrior1YTDDuration1138307000JPY
Selling general and administrative expensesCurrentYTDDuration1068482000JPY
Operating incomePrior1YTDDuration-777339000JPY
Operating incomeCurrentYTDDuration-312016000JPY
Interest income noiPrior1YTDDuration57000JPY
Interest income noiCurrentYTDDuration57000JPY
Dividends income noiPrior1YTDDuration198000JPY
Dividends income noiCurrentYTDDuration204000JPY
Subsidy income noiPrior1YTDDuration7200000JPY
Subsidy income noiCurrentYTDDuration-JPY
Foreign exchange gains noiPrior1YTDDuration-JPY
Foreign exchange gains noiCurrentYTDDuration7918000JPY
Other noiPrior1YTDDuration789000JPY
Other noiCurrentYTDDuration2396000JPY
Non operating incomePrior1YTDDuration8245000JPY
Non operating incomeCurrentYTDDuration10576000JPY
Interest expenses noePrior1YTDDuration2194000JPY
Interest expenses noeCurrentYTDDuration3063000JPY
Guarantee commission noePrior1YTDDuration726000JPY
Guarantee commission noeCurrentYTDDuration492000JPY
Stock issuance cost noePrior1YTDDuration208000JPY
Stock issuance cost noeCurrentYTDDuration1434000JPY
Foreign exchange losses noePrior1YTDDuration2476000JPY
Foreign exchange losses noeCurrentYTDDuration-JPY
Other noePrior1YTDDuration30000JPY
Other noeCurrentYTDDuration-JPY
Non operating expensesPrior1YTDDuration5637000JPY
Non operating expensesCurrentYTDDuration4991000JPY
Ordinary incomePrior1YTDDuration-774731000JPY
Ordinary incomeCurrentYTDDuration-306431000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2021-12-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-12-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-01-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass